📰 Abt News
Page 139 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
June 18, 2023
Arcblock (ABT) traded down 13.6% against the US dollar during the 1 day period ending at 20:00 PM E.T. on June 17th. One Arcblock token can now be purchased for about $0.0786 or 0.00000297 BTC on popular exchanges. Arcblock has a total market capitalization of $7.75 million and $160,165.64 worth of Arcblock was traded on […]
June 18, 2023
Metropolitan Life Insurance Co. NY cut its stake in Abbott Laboratories (NYSE:ABT – Get Rating) by 3.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 98,718 shares of the healthcare product maker’s stock after selling 3,579 shares during the quarter. Metropolitan […]
June 18, 2023
Campion Asset Management reduced its position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 4.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,438 shares of the healthcare product maker’s stock after selling 225 shares during the […]
June 17, 2023
Arcblock (ABT) traded up 12.9% against the U.S. dollar during the 24 hour period ending at 23:00 PM ET on June 16th. Arcblock has a market capitalization of $8.97 million and approximately $264,518.88 worth of Arcblock was traded on exchanges in the last 24 hours. One Arcblock token can now be bought for $0.0910 or […]
June 17, 2023
First Financial Bank Trust Division trimmed its position in Abbott Laboratories (NYSE:ABT – Get Rating) by 0.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 131,474 shares of the healthcare product maker’s stock after selling 1,103 shares during the quarter. Abbott […]
June 17, 2023
Keel Point LLC boosted its position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 37.8% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,335 shares of the healthcare product maker’s stock after buying an additional 1,737 shares during the quarter. Keel Point […]
June 17, 2023
Private Asset Management Inc. lessened its stake in Abbott Laboratories (NYSE:ABT – Get Rating) by 2.2% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 7,106 shares of the healthcare product maker’s stock after selling 158 shares during the period. Private Asset Management Inc.’s holdings in Abbott Laboratories […]
June 16, 2023
Arcblock (ABT) traded up 13% against the U.S. dollar during the twenty-four hour period ending at 21:00 PM E.T. on June 15th. One Arcblock token can now be bought for about $0.0809 or 0.00000318 BTC on cryptocurrency exchanges. During the last seven days, Arcblock has traded 4.6% lower against the U.S. dollar. Arcblock has a […]
June 16, 2023
ST Germain D J Co. Inc. grew its stake in Abbott Laboratories (NYSE:ABT – Get Rating) by 25.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 27,256 shares of the healthcare product maker’s stock after acquiring an additional 5,561 shares […]
June 16, 2023
Chelsea Counsel Co. trimmed its position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 4.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 23,823 shares of the healthcare product maker’s stock after selling 1,050 shares during the period. Abbott Laboratories comprises […]